Page last updated: 2024-10-25

deferoxamine and Schistosomiasis mansoni

deferoxamine has been researched along with Schistosomiasis mansoni in 4 studies

Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.

Schistosomiasis mansoni: Schistosomiasis caused by Schistosoma mansoni. It is endemic in Africa, the Middle East, South America, and the Caribbean and affects mainly the bowel, spleen, and liver.

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's1 (25.00)24.3611
2020's2 (50.00)2.80

Authors

AuthorsStudies
Mielke, N1
Johnson, S1
Bahl, A1
Fadladdin, YAJ1
Xue, M1
Zhang, X1
Chen, J1
Liu, F1
Xu, J1
Xie, J1
Yang, Y1
Yu, W1
Qiu, H1
Xue, J1
Jiang, J1
Liu, Y2
Shallom, SJ1
Zelazny, AM1
Giri, AR1
Kaur, N1
Yarrarapu, SNS1
Rottman Pietrzak, KA1
Santos, C1
Lowman, PE1
Niaz, S1
Franco, PM1
Sanghavi, DK1
Zhu, D1
Liang, R1
Li, Z2
Cheng, L1
Ren, J1
Guo, Y1
Wang, M1
Chai, H1
Niu, Q1
Yang, S1
Bai, J1
Yu, H1
Zhang, H1
Qin, X1
Sahrakorpi, N1
Engberg, E1
Stach-Lempinen, B1
Tammelin, TH1
Kulmala, J1
Roine, RP1
Koivusalo, SB1
Cheng, W1
Pang, H1
Campen, MJ1
Zhang, J2
Li, Y1
Gao, J1
Ren, D1
Ji, X1
Rothman, N1
Lan, Q1
Zheng, Y1
Leng, S1
Hu, Z1
Tang, J1
Dong, Q1
Song, N1
Qin, N1
Chen, C1
Sun, X1
Easton, J1
Mulder, H1
Plyler, E1
Neale, G1
Walker, E1
Li, Q1
Ma, X1
Chen, X1
Huang, IC1
Yasui, Y1
Ness, KK1
Hudson, MM1
Robison, LL1
Wang, Z1
Subota, A1
Spotswood, N1
Roach, M1
Goodarzi, Z1
Holroyd-Leduc, J1
Park, EA1
Graves, SA1
Menda, Y1
Gasparotto, J1
Senger, MR1
Telles de Sá Moreira, E1
Brum, PO1
Carazza Kessler, FG1
Peixoto, DO1
Panzenhagen, AC1
Ong, LK1
Campos Soares, M1
Reis, PA1
Schirato, GV1
Góes Valente, WC1
Araújo Montoya, BO1
Silva, FP1
Fonseca Moreira, JC1
Dal-Pizzol, F1
Castro-Faria-Neto, HC1
Gelain, DP1
Abdelgelil, NH1
Abdellatif, MZM1
Abdel-Hafeez, EH1
Belal, US1
Mohamed, RM1
Abdel-Razik, AH1
Hassanin, KMA1
Abdel-Wahab, A1
Hahn, UK1
Bender, RC1
Bayne, CJ1

Reviews

1 review available for deferoxamine and Schistosomiasis mansoni

ArticleYear
    Lancet regional health. Americas, 2022, Volume: 8

    Topics: Adult; Aging; Aluminum; Alzheimer Disease; Animals; Anti-Bacterial Agents; Artemisia annua; Body Mas

2022

Other Studies

3 other studies available for deferoxamine and Schistosomiasis mansoni

ArticleYear
Neurological impairment caused by Schistosoma mansoni systemic infection exhibits early features of idiopathic neurodegenerative disease.
    The Journal of biological chemistry, 2021, Volume: 297, Issue:2

    Topics: Acetylcysteine; Animals; Anthelmintics; Astrocytes; Deferoxamine; Disease Models, Animal; Free Radic

2021
Effects of iron chelating agent on Schistosoma mansoni infected murine model.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2019, Volume: 109

    Topics: Animals; Deferoxamine; Disease Models, Animal; Granuloma; Iron Chelating Agents; Liver Cirrhosis; Li

2019
Involvement of nitric oxide in killing of Schistosoma mansoni sporocysts by hemocytes from resistant Biomphalaria glabrata.
    The Journal of parasitology, 2001, Volume: 87, Issue:4

    Topics: Animals; Biomphalaria; Deferoxamine; Drug Antagonism; Hemocytes; Immunity, Innate; Nitrates; Nitric

2001